个性化文献订阅>期刊> Anticancer Research
 

Expression of p53, Ki-67, E-Cadherin, N-Cadherin and TOP2A in Triple-negative Breast Cancer

  作者 Nakagawa, M; Bando, Y; Nagao, T; Morimoto, M; Takai, C; Ohnishi, T; Honda, J; Moriya, T; Izumi, K; Takahashi, M; Sasa, M; Tangoku, A  
  选自 期刊  Anticancer Research;  卷期  2011年31-6;  页码  2389-2393  
  关联知识点  
 

[摘要]Background: Elucidation of the biological features of triple negative breast cancer (TNBC) is important for deciding treatment strategies. The expression of a number of biomarkers in TNBC was analyzed to elucidate those features. Patients and Methods: The subjects were 134 TNBC patients. Immunohistochemical staining was employed to analyze for eight biomarkers: cytokeratin 516 (CK5/6), epidermal growth factor receptor (EGFR), p53, Ki-67 antigen (Ki-67), E-cadherin, N-cadherin, topoisomerase 2 alpha (TOP2A) and B-cell lymphoma 2 (BCL-2), which were then correlated with the nuclear grade (NG), tumor diameter, and the presence/absence of lymph node metastasis, distant recurrence and lymphatic infiltration. Results: Significantly more high than low NG TNBC exhibited positive p53, Ki-67, E-cadherin and TOP2A. High N-cadherin and TOP2A expression was shown significantly in TNBC with lymphatic infiltration, and N-cadherin was also significantly positively expressed in node metastasis-positive cases. EGFR and CK5/6 were positively expressed in high NG TNBC, but not significantly. Conclusion: Analysis for expression of p53, Ki-67, E-cadherin, N-cadherin and TOP2A is meaningful for deciding treatment strategies for TNBC.

 
      被申请数(0)  
 

[全文传递流程]

一般上传文献全文的时限在1个工作日内